1. Safety of denosumab in dialysis patients on calcium and vitamin D supplements.
- Author
-
Ullah A, Abdulnabi K, Khalil A, Alexander J, Pai P, and Mishra V
- Subjects
- Aged, Biomarkers blood, Calcium adverse effects, Calcium blood, Fatal Outcome, Humans, Hypocalcemia blood, Hypocalcemia diagnosis, Male, Middle Aged, Osteoporosis blood, Osteoporosis complications, Osteoporosis diagnosis, Remission Induction, Renal Insufficiency, Chronic blood, Renal Insufficiency, Chronic complications, Renal Insufficiency, Chronic diagnosis, Severity of Illness Index, Treatment Outcome, Vitamin D adverse effects, Bone Density Conservation Agents adverse effects, Calcium therapeutic use, Denosumab adverse effects, Dietary Supplements adverse effects, Hypocalcemia chemically induced, Osteoporosis drug therapy, Renal Dialysis adverse effects, Renal Insufficiency, Chronic therapy, Vitamin D therapeutic use
- Published
- 2017
- Full Text
- View/download PDF